|
1）ISHLT home page on the Internet. http://www.ishlt.org/
|
|
|
|
|
2）日本肺及び心肺移植研究会. Home page on the Internet. http://www.hai-isyoku.jp/index.html
|
|
|
|
|
|
3）McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011; 364: 1595-606
|
|
|
|
|
4）Estenne M, de Francquen P, Wellens F, et al. Combined heart-and-lung transplantation for lymphangioleiomyomatosis. Lancet. 1984; 1: 275
|
|
|
|
|
|
5）Lizotte PE, Whitlock WL, Prudhomme JC, et al. lymphangiomyomatosis. Chest. 1990; 98: 1044-5
|
|
|
|
|
|
6）松村輔二, 岡田克典, 近藤 丘, 他．本邦初の脳死肺移植―右片肺移植―.今日の移植. 2000; 13: 418-25
|
|
|
|
|
7）Benden C, Rea F, Behr J, et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant. 2009; 28: 1-7
|
|
|
|
|
|
8）平間未知大, 近藤 丘, 瀬山邦明，他. リンパ脈管筋腫症（LAM）の最新の話題.呼吸と循環. 2009; 57: 395-408
|
|
|
|
|
9）Hayashida M, Seyama K, Inoue Y, et al. The epidemiology of lymphangioleiomyomatosis in Japan. Respirology. 2007; 12: 523-30
|
|
|
|
|
|
10）Almoosa KF, Ryu JH, Mendez J, et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest. 2006; 129: 1274-81
|
|
|
|
|
|
11）Young LR, Almoosa KF, Pollock-Barziv S. Patient perspectives on management of pneumothorax in lymphangioleiomyomatosis. Chest. 2006; 129（5）: 1267-73
|
|
|
|
|
|
12）Kurihara M, Kataoka H, Ishikawa A,et al. Latest treatments for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg. 2010; 58: 113-9
|
|
|
|
|
|
13）Noda M, Okada Y, Kondo T, et al. A total pleural covering technique in patients with intractable bilateral secondary spontaneous pneumothorax: Report of five cases. Surg Today. 2011; 41: 1414-7
|
|
|
|
|
|
14）Sugimoto R, Nakao A, Yamane M, et al. Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. J Heart Lung Transplant. 2008; 27（8）: 921-4
|
|
|
|
|
|
15）Okada Y, Kondo T. Impact of lung preservation solutions, Euro-Collins vs. low-potassium dextran, on early graft function: a review of five clinical studies. Ann Thorac Cardiovasc Surg. 2006; 12: 10-4
|
|
|
|
|
|
16）岡田克典, 近藤 丘. 肺移植の現状と課題.日本胸部臨床. 2009; 68: 897-904
|
|
|
|
|
|
17）Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med. 2004 ; 351: 2730-9
|
|
|
|
|
|
18）Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008; 85:278-86
|
|
|
|
|
|
19)Sugita M, Noda M, Suzuki S, et al. Transalveolar fluid absorption ability in rat lungs preserved with Euro-Collins solution and EP4 solution. Transplantation. 1999; 67: 349-54
|
|
|
|
|
|
20）Noda M, Suzuki S, Tsubochi H, et al. Single dexamethasone injection increases alveolar fluid clearance in adult rats. Crit Care Med. 2003; 31: 1183-9
|
|
|
|
|
|
21）Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011; 364: 1431-40
|
|
|
|
|
|
22）Snell GI, Levvey BJ, Oto T, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant. 2008; 8: 1282-9
|
|
|
|
|
|
23）Iacono AT, Johnson BA, Grgurich WF, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006; 354: 141-50
|
|
|
|
|
|
24）Fietta AM, Meloni F. Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome. Curr Med Chem. 2008; 15: 716-23
|
|
|
|
|